HIV-exposed uninfected infants in Zimbabwe: Insights into health outcomes in the pre-antiretroviral therapy era

Frontiers in Immunology

Volumn 7, Issue JUN, 2016, Pages

  Evans, Ceri ^a,b   Humphrey, Jean H ^a,c   Ntozini, Robert ^a   Prendergast, Andrew J ^a,b,c  

^a Zvitambo Institute for Maternal and Child Health Research   (Zimbabwe)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Africa; Breast feeding; HIV exposure; Immune activation; Infant; Inflammation; Zimbabwe

Indexed keywords

RETINOL;

ARTICLE; BREAST FEEDING; CONCEPTUAL FRAMEWORK; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; ENTEROPATHY; GROWTH DISORDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; MIXED INFECTION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SEROCONVERSION; SOCIOECONOMICS; ZIMBABWE;

EID: 84977516762     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00190     Document Type: Article

References (118)

1. Humphrey JH, IliffPJ, Marinda ET, Mutasa K, Moulton LH, Chidawanyika H, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis (2006) 193(6):860-71. doi: 10.1086/500366
2. Marinda E, Humphrey JH, IliffPJ, Mutasa K, Nathoo KJ, Piwoz EG, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J (2007) 26(6):519-26. doi:10.1097/01.inf.0000264527.69954.4c
3. Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis (2016) 16(6):e92-107. doi:10.1016/S1473-3099(16)00055-4
4. Malaba LC, IliffPJ, Nathoo KJ, Marinda E, Moulton LH, Zijenah LS, et al. Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe. Am J Clin Nutr (2005) 81(2):454-60.
5. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, IliffP, et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J (2011) 30(1):45-51. doi:10.1097/INF.0b013e3181ecbf7e
6. Cohen C, Moyes J, Tempia S, Groome M, Walaza S, Pretorius M, et al. Epidemiology of acute lower respiratory Tract infection in HIV-exposed uninfected infants. Pediatrics (2016). doi:10.1542/peds.2015-3272
7. Gaensbauer J, Rakhola JT, Onyango-Makumbi C, Mubiru M, Westcott JE, Krebs NF, et al. Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but uninfected infants. Clin Vaccine Immunol (2014) 21(12):1661-7. doi:10.1128/CVI.00356-14
8. Jones C, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling A. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA (2011) 305(6):576-84. doi:10.1001/jama.2011.100
9. Jones C, Pollock L, Barnett S, Battersby A, Kampmann B. Specific antibodies against vaccine-preventable infections: a mother-infant cohort study. BMJ Open (2013) 3(4). doi:10.1136/bmjopen-2012-002473
10. Madhi S, Izu A, Violari A, Cotton MF, Panchia R, Dobbels E, et al. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and uninfected infants. Vaccine (2013) 31(5):777-83. doi:10.1016/j.vaccine.2012.11.076
11. Simani O, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, et al. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS (2014) 28(4):531-41. doi:10.1097/QAD.0000000000000127
12. Cumberland P, Shulman CE, Maple PA, Bulmer JN, Dorman EK, Kawuondo K, et al. HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis (2007) 196(4):550-7. doi:10.1086/519845
13. Miles D, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology (2010) 129(3):446-54. doi:10.1111/j.1365-2567.2009.03186.x
14. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood (2000) 96(12):3866-71.
15. Moraleda C, de Deus N, Serna-Bolea C, Renom M, Quintó L, Macete E, et al. Impact of HIV exposure on health outcomes in HIV-negative infants born to HIV-positive mothers in Sub-Saharan Africa. J Acquir Immune Defic Syndr (2014) 65(2):182-9. doi:10.1097/QAI.0000000000000019
16. Kidzeru EB, Hesseling AC, Passmore JA, Myer L, Gamieldien H, Tchakoute CT, et al. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS (2014) 28(10):1421-30. doi:10.1097/QAD.0000000000000292
17. Ono E, Nunes dos Santos AM, de Menezes Succi RC, Machado DM, de Angelis DS, Salomão R, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res (2008) 41(8):700-8. doi:10.1590/S0100-879X2008000800011
18. + lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol (1997) 4(3):358-61.
19. Romano MF, Buffolano W, Bisogni R, Russo R, Liuzzi R, Bunders M, et al. Increased CD154 expression in uninfected infants born to HIV-positive mothers exposed to antiretroviral prophylaxis. Viral Immunol (2006) 19(3):363-72. doi:10.1089/vim.2006.19.363
20. Bunders M, van Hamme JL, Jansen MH, Boer K, Kootstra NA, Kuijpers TW. Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1. Sci Rep (2014) 4:6690. doi:10.1038/srep06690
21. Jones C, Hesseling AC, Tena-Coki NG, Scriba TJ, Chegou NN, Kidd M, et al. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination. AIDS (2015) 29(2):155-65. doi:10.1097/QAD.0000000000000536
22. Reikie BA, Adams RC, Leligdowicz A, Ho K, Naidoo S, Ruck CE, et al. Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr (2014) 66(3):245-55. doi:10.1097/QAI.0000000000000161
23. Slyker J, Lohman-Payne B, John-Stewart GC, Dong T, Mbori-Ngacha D, Tapia K, et al. The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life. Front Immunol (2012) 3:399. doi:10.3389/fimmu.2012.00399
24. Velilla P, Montoya C, Hoyos A, Moreno M, Chougnet C, Rugeles M. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol (2008) 126(3):243-50. doi:10.1016/j.clim.2007.11.004
25. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis (1999) 179(4):859-70. doi:10.1086/314660
26. Tesselaar K, Arens R, van Schijndel GM, Baars PA, van der Valk MA, Borst J, et al. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat Immunol (2003) 4(1):49-54. doi:10.1038/ni869
27. Kuhn L, Meddows-Taylor S, Gray G, Tiemessen C. Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis (2002) 34(2):267-76. doi:10.1086/338153
28. Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS One (2006) 1:e102. doi:10.1371/journal.pone.0000102
29. Liu A, Lohman-Payne B, Chung MH, Kiarie J, Kinuthia J, Slyker J, et al. Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya. Clin Exp Immunol (2015) 180(3):509-19. doi:10.1111/cei.12599
30. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet (1990) 335(8689):565-8. doi:10.1016/0140-6736(90)90349-A
31. McGann KA, Collman R, Kolson DL, Gonzalez-Scarano F, Coukos G, Coutifaris C, et al. Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis (1994) 169(4):746-53. doi:10.1093/infdis/169.4.746
32. Hanna Z, Priceputu E, Hu C, Vincent P, Jolicoeur P. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice. Virology (2006) 346(1):40-52. doi:10.1016/j.virol.2005.10.010
33. Priceputu E, Hanna Z, Hu C, Simard MC, Vincent P, Wildum S, et al. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice. J Virol (2007) 81(9):4677-93. doi:10.1128/JVI.02691-06
34. Singh P, Agnihotri SK, Tewari MC, Kumar S, Sachdev M, Tripathi RK. HIV-1 Nef breaches placental barrier in rat model. PLoS One (2012) 7(12):e51518. doi:10.1371/journal.pone.0051518
35. Ellington SR, Clarke KE, Kourtis AP. Cytomegalovirus infection in the human immunodeficiency virus-exposed and infected infant: a systematic review. J Infect Dis (2015) 213(6):891-900. doi:10.1093/infdis/jiv549
36. Mwaanza N, Chilukutu L, Tembo J, Kabwe M, Musonda K, Kapasa M, et al. High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin Infect Dis (2014) 58(5):728-35. doi:10.1093/cid/cit766
37. Elbou Ould MA, Luton D, Yadini M, Pedron B, Aujard Y, Jacqz-Aigrain E, et al. Cellular immune response of fetuses to cytomegalovirus. Pediatr Res (2004) 55(2):280-6. doi:10.1203/01.PDR.0000104150.85437.FE
38. Miles DJ, Sanneh M, Holder B, Crozier S, Nyamweya S, Touray ES, et al. Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants. Immunology (2008) 124(3):388-400. doi:10.1111/j.1365-2567.2007.02787.x
39. Miles DJ, van der Sande M, Jeffries D, Kaye S, Ojuola O, Sanneh M, et al. Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One (2008) 3(8):e2905. doi:10.1371/journal.pone.0002905
40. Miles DJ, van der Sande M, Jeffries D, Kaye S, Ismaili J, Ojuola O, et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol (2007) 81(11):5766-76. doi:10.1128/JVI.00052-07
41. Gumbo H, Chasekwa B, Church JA, Ntozini R, Mutasa K, Humphrey JH, et al. Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants. PLoS One (2014) 9(12):e114870. doi:10.1371/journal.pone.0114870
42. Slyker JA, Lohman-Payne BL, John-Stewart GC, Maleche-Obimbo E, Emery S, Richardson B, et al. Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS (2009) 23(16):2173-81. doi:10.1097/QAD.0b013e32833016e8
43. Gompels UA, Larke N, Sanz-Ramos M, Bates M, Musonda K, Manno D, et al. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis (2012) 54(3):434-42. doi:10.1093/cid/cir837
44. Slyker J, Lohman-Payne BL, Rowland-Jones SL, Otieno P, Maleche-Obimbo E, Richardson B, et al. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS (2009) 23(1):117-24. doi:10.1097/QAD.0b013e32831c8abd
45. Hsiao N, Zampoli M, Morrow B, Zar HJ, Hardie D. Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. J Clin Virol (2013) 58(1):74-8. doi:10.1016/j.jcv.2013.05.002
46. Mocarski EJ. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol (2002) 10(7):332-9. doi:10.1016/S0966-842X(02)02393-4
47. Loenen W, Bruggeman CA, Wiertz EJ. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin Immunol (2001) 13(1):41-9. doi:10.1006/smim.2001.0294
48. van de Berg P, Heutinck KM, Raabe R, Minnee RC, Young SL, van Donselaar-van der Pant KA, et al. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis (2010) 202(5):690-690. doi:10.1086/655472
49. Scott G, Chow SS, Craig ME, Pang CN, Hall B, Wilkins MR, et al. Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis (2012) 205(8):1305-10. doi:10.1093/infdis/jis186
50. Tan Y, Yu SJ, Wang J, Li SJ. Role of Treg/Th17 balance in the pathogenesis of cytomegalovirus infection. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2012) 28(6):649-51.
51. Crome S, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol (2010) 159(2):109-19. doi:10.1111/j.1365-2249.2009.04037.x
52. Khan N, Hislop A, Gudgeon N, Cobbold M, Khanna R, Nayak L, et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J Immunol (2004) 173(12):7481-9. doi:10.4049/jimmunol.173.12.7481
53. Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, Van Rysselberge M, et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med (2010) 207(4):807-21. doi:10.1084/jem.20090348
54. Noyola DE, Fortuny C, Muntasell A, Noguera-Julian A, Muñoz-Almagro C, Alarcón A, et al. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur J Immunol (2012) 42(12):3256-66. doi:10.1002/eji.201242752
55. Marchant A, Appay V, Van Der Sande M, Dulphy N, Liesnard C, Kidd M, et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest (2003) 111(11):1747-55. doi:10.1172/JCI200317470
56. Roxby A, Atkinson C, Asbjörnsdóttir K, Farquhar C, Kiarie JN, Drake AL, et al. Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women. PLoS One (2014) 9(2):e87855. doi:10.1371/journal.pone.0087855
57. Gantt S, Leister E, Jacobson DL, Boucoiran I, Huang ML, Jerome KR, et al. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy. J Med Virol (2016) 88(6):1051-8. doi:10.1002/jmv.24420
58. Richardson B, John-Stewart G, Emery V, Atkinson C, Nduati R, Ásbjörnsdóttir K, et al. CMV Transmission from HIV-Infected Women Randomized to Formula Versus Breastfeeding. Conference on Retroviruses and Opportunistic Infections. Seattle, WA: (2015).
59. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 12(12):1365-71. doi:10.1038/nm1511
60. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, McClure HM, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity (2003) 18(3):441-52. doi:10.1016/S1074-7613(03)00060-8
61. López M, Figueras F, Coll O, Goncé A, Hernández S, Loncá M, et al. Inflammatory markers related to microbial translocation among HIV-infected pregnant women: a risk factor of preterm delivery. J Infect Dis (2016) 213(3):343-50. doi:10.1093/infdis/jiv416
62. Cardenas I, Mor G, Aldo P, Lang SM, Stabach P, Sharp A, et al. Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis. Am J Reprod Immunol (2011) 65(2):110-7. doi:10.1111/j.1600-0897.2010.00908.x
63. Kohmura Y, Kirikae T, Kirikae F, Nakano M, Sato I. Lipopolysaccharide (LPS)-induced intra-uterine fetal death (IUFD) in mice is principally due to maternal cause but not fetal sensitivity to LPS. Microbiol Immunol (2000) 44(11):897-904. doi:10.1111/j.1348-0421.2000.tb02581.x
64. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis (2003) 187(10):1534-43. doi:10.1086/374786
65. Almeida CA, Price P, French MA. Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2002) 18(18):1351-5. doi:10.1089/088922202320935429
66. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 201(12):1788-95. doi:10.1086/652749
67. Somsouk M, Estes JD, Deleage C, Dunham RM, Albright R, Inadomi JM, et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS (2015) 29(1):43-51. doi:10.1097/QAD.0000000000000511
68. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, Gray-Owen SD, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog (2010) 6(4):e1000852. doi:10.1371/journal.ppat.1000852
69. Moodley-Govender E, Mulol H, Stauber J, Manary M, Coutsoudis A. Increased exclusivity of breastfeeding associated with reduced gut inflammation in infants. Breastfeed Med (2015) 10:488-92. doi:10.1089/bfm.2015.0110
70. Kourtis AP, Ibegbu CC, Wiener J, King CC, Tegha G, Kamwendo D, et al. Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study. J Infect Dis (2013) 208(4):653-61. doi:10.1093/infdis/jit221
71. Schramm D, Kuhn L, Gray G, Tiemessen C. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr (2006) 42(5):545-53. doi:10.1097/01.qai.0000225009.30698.ce
72. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet (2013) 382(9890):427-51. doi:10.1016/S0140-6736(13)60937-X
73. Kuzawa CW, Tallman PS, Adair LS, Lee N, McDade TW. Inflammatory profiles in the non-pregnant state predict offspring birth weight at Cebu: evidence for inter-generational effects of low grade inflammation. Ann Hum Biol (2012) 39(4):267-74. doi:10.3109/03014460.2012.692810
74. Kumar RM, Uduman SA, Khurranna AK. Impact of maternal HIV-1 infection on perinatal outcome. Int J Gynaecol Obstet (1995) 49(2):137-43. doi:10.1016/0020-7292(95)02356-H
75. Dreyfuss ML, Msamanga GI, Spiegelman D, Hunter DJ, Urassa EJ, Hertzmark E, et al. Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr (2001) 74(6):814-26.
76. Kalanda BF, van Buuren S, VerhoeffFH, Brabin BJ. Anthropometry of fetal growth in rural Malawi in relation to maternal malaria and HIV status. Arch Dis Child Fetal Neonatal Ed (2005) 90(2):F161-5. doi:10.1136/adc.2004.054650
77. Kfutwah A, Mary JY, Lemen B, Leke R, Rousset D, Barré-Sinoussi F, et al. Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women. PLoS One (2009) 4(12):e8114. doi:10.1371/journal.pone.0008114
78. Jones AD, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MN, et al. Acute illness is associated with suppression of the growth hormone axis in Zimbabwean infants. Am J Trop Med Hyg (2015) 92(2):463-70. doi:10.4269/ajtmh.14-0448
79. Prendergast A, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MN, et al. Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS One (2014) 9(2):e86928. doi:10.1371/journal.pone.0086928
80. Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature (2014) 510(7505):417-21. doi:10.1038/nature13421
81. Kau AL, Planer JD, Liu J, Rao S, Yatsunenko T, Trehan I, et al. Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy. Sci Transl Med (2015) 7(276):276ra24. doi:10.1126/scitranslmed.aaa4877
82. Reyes A, Blanton LV, Cao S, Zhao G, Manary M, Trehan I, et al. Gut DNA viromes of Malawian twins discordant for severe acute malnutrition. Proc Natl Acad Sci U S A (2015) 112(38):11941-6. doi:10.1073/pnas.1514285112
83. Crane RJ, Jones KD, Berkley JA. Environmental enteric dysfunction: an overview. Food Nutr Bull (2015) 36(1 Suppl):S76-87. doi:10.1177/15648265150361S113
84. Prendergast A, Kelly P. Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg (2012) 86(5):756-63. doi:10.4269/ajtmh.2012.11-0743
85. Keusch G, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, et al. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis (2014) 59(Suppl 4):S207-12. doi:10.1093/cid/ciu485
86. Funkhouser L, Bordenstein SR. Mom knows best: the universality of maternal microbial transmission. PLoS Biol (2013) 11(8):e1001631. doi:10.1371/journal.pbio.1001631
87. Lozupone C, Li M, Campbell TB, Flores SC, Linderman D, Gebert MJ, et al. Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe (2013) 14(3):329-39. doi:10.1016/j.chom.2013.08.006
88. Monaco CL, Gootenberg DB, Zhao G, Handley SA, Ghebremichael MS, Lim ES, et al. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome. Cell Host Microbe (2016) 19(3):311-22. doi:10.1016/j.chom.2016.02.011
89. Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P, St Louis ME. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. Int J Epidemiol (1999) 28(3):532-40. doi:10.1093/ije/28.3.532
90. Christian P, Lee SE, Donahue Angel M, Adair LS, Arifeen SE, Ashorn P, et al. Risk of childhood undernutrition related to small-for-gestational age and preterm birth in low-and middle-income countries. Int J Epidemiol (2013) 42(5):1340-55. doi:10.1093/ije/dyt109
91. Turner AN, Tabbah S, Mwapasa V, Rogerson SJ, Meshnick SR, Ackerman WE IV, et al. Severity of maternal HIV-1 disease is associated with adverse birth outcomes in Malawian women: a cohort study. J Acquir Immune Defic Syndr (2013) 64(4):392-9. doi:10.1097/QAI.0b013e3182a2d13c
92. McGrath CJ, Nduati R, Richardson BA, Kristal AR, Mbori-Ngacha D, Farquhar C, et al. The prevalence of stunting is high in HIV-1-exposed uninfected infants in Kenya. J Nutr (2012) 142(4):757-63. doi:10.3945/jn.111.148874
93. Jao J, Agwu A, Mhango G, Kim A, Park K, Posada R, et al. Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women. AIDS (2015) 29(1):111-6. doi:10.1097/QAD.0000000000000501
94. Muhangi L, Lule SA, Mpairwe H, Ndibazza J, Kizza M, Nampijja M, et al. Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, Uganda. Public Health Nutr (2013) 16(9):1548-57. doi:10.1017/S1368980013000499
95. Powis KM, Quanhong L, Chinyanga Y, Tumbare E, Khan N, Sibiya J, et al. Malnutrition among HIV-Exposed Uninfected Children in Botswana. Conference on Retroviruses and Opportunistic Infections. Seattle, WA: (2015).
96. Slogrove A, Reikie B, Naidoo S, De Beer C, Ho K, Cotton M, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr (2012) 58(6):505-8. doi:10.1093/tropej/fms019
97. Landes M, van Lettow M, Chan AK, Mayuni I, Schouten EJ, Bedell RA. Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi. PLoS One (2012) 7(10):e47337. doi:10.1371/journal.pone.0047337
98. Kerr SJ, Puthanakit T, Vibol U, Aurpibul L, Vonthanak S, Kosalaraksa P, et al. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care (2014) 26(11):1327-35. doi:10.1080/09540121.2014.920949
99. Osterbauer B, Kapisi J, Bigira V, Mwangwa F, Kinara S, Kamya MR, et al. Factors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey. Malar J (2012) 11:432. doi:10.1186/1475-2875-11-432
100. Mofenson LM. Antiretroviral therapy and adverse pregnancy outcome: the elephant in the room? J Infect Dis (2016) 213(7):1051-4. doi:10.1093/infdis/jiv390
101. Fowler M, Qin M, Shapiro D, Fiscus S. PROMISE: Efficacy and Safety of Two Strategies to Prevent Perinatal HIV Transmission. Conference on Retroviruses and Opportunistic Infections. Seattle, WA: (2015).
102. Powis KM, Kitch D, Ogwu A, Hughes MD, Lockman S, Leidner J, et al. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis (2011) 204(4):506-14. doi:10.1093/infdis/jir307
103. Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, et al. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir-or efavirenz-based antiretroviral therapy. J Acquir Immune Defic Syndr (2014) 67(2):128-35. doi:10.1097/QAI.0000000000000281
104. Kourtis AP, Fowler MG. Antiretroviral use during pregnancy and risk of preterm delivery: more questions than answers. J Infect Dis (2011) 204(4):493-4. doi:10.1093/infdis/jir318
105. Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis (2012) 206(11):1695-705. doi:10.1093/infdis/jis553
106. Li N, Sando MM, Spiegelman D, Hertzmark E, Liu E, Sando D, et al. Antiretroviral therapy in relation to birth outcomes among HIV-infected women: a cohort study. J Infect Dis (2016) 213(7):1057-64. doi:10.1093/infdis/jiv389
107. Powis KM, Smeaton L, Ogwu A, Lockman S, Dryden-Peterson S, van Widenfelt E, et al. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana. J Acquir Immune Defic Syndr (2011) 56(2):131-8. doi:10.1097/QAI.0b013e3181ffa4f5
108. Joint United National Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic. Geneva, Switzerland: WHO (2013).
109. Homsy J, Moore D, Barasa A, Were W, Likicho C, Waiswa B, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2010) 53(1):28-35. doi:10.1097/QAI.0b013e3181bdf65a
110. IliffPJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS (2005) 19(7):699-708. doi:10.1097/01.aids.0000166093.16446.c9
111. UNAIDS/UNICEF/WHO. HIV and Infant Feeding: Guidelines for Decision-Makers. Geneva, Switzerland: WHO (1998).
112. Piwoz EG, IliffPJ, Tavengwa N, Gavin L, Marinda E, Lunney K, et al. An education and counseling program for preventing breast-feeding-associated HIV transmission in Zimbabwe: design and impact on maternal knowledge and behavior. J Nutr (2005) 135(4):950-5.
113. Kuhn L. Milk mysteries: why are women who exclusively breast-feed less likely to transmit HIV during breast-feeding? Clin Infect Dis (2010) 50(5):770-2. doi:10.1086/650536
114. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr (2000) 30(1):61-7. doi:10.1097/00005176-200001000-00019
115. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr (1999) 69(5):1035S-45S.
116. Desai A, Mbuya MN, Chigumira A, Chasekwa B, Humphrey JH, Moulton LH, et al. Traditional oral remedies and perceived breast milk insufficiency are major barriers to exclusive breastfeeding in rural Zimbabwe. J Nutr (2014) 144(7):1113-9. doi:10.3945/jn.113.188714
117. Desai A, Smith LE, Mbuya MN, Chigumira A, Fundira D, Tavengwa NV, et al. The SHINE trial infant feeding intervention: pilot study of effects on maternal learning and infant diet quality in rural Zimbabwe. Clin Infect Dis (2015) 61(Suppl 7):S710-5. doi:10.1093/cid/civ846
118. Matare CR, Mbuya MNN, Tavengwa NV, Ntozini R, Stoltzfus RJ, Humphrey JH. A Culturally Appropriate Intervention Delivered by Village Health Workers Increases the Prevalence of Exclusive Breastfeeding in Rural Zimbabwe. Abstract Presented at the 18th International Society for Research in Human Milk and Lactation. Stellenbosch, South Africa: (2016).